CLINICAL TRIALS PROFILE FOR JAYPIRCA
✉ Email this page to a colleague
All Clinical Trials for jaypirca
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT05990465 ↗ | LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies | Not yet recruiting | Medical College of Wisconsin | Phase 1 | 2024-07-01 | This is a phase I, interventional, single arm, open label, treatment study designed to evaluate the safety and efficacy of LV20.19 CAR -T cells with pirtobrutinib bridging and maintenance in adult patients with B cell malignancies that have failed prior therapies. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for jaypirca
Condition Name
Clinical Trial Progress for jaypirca
Clinical Trial Phase
Clinical Trial Sponsors for jaypirca
Sponsor Name